In a previous piece, I explored how eight independent research teams converged on the same insight: instead of building memory systems around the model, train the model itself to manage memory as a learned skill. Post-memory training — using reinforcement learning in the post-training phase — produces agents that decide what to store, delete, consolidate, and retrieve, all optimized against task completion.
Post-memory training has been a hyperfocus of mine over the past few months. If you have followed my recent writing on context management, memory architectures, and the recurring question of why agents degrade after turn 50, this article is where those threads converge. The original pattern was clear enough. Eight independent research teams arrived at the same conclusion: stop building memory systems around the model and train the model itself to manage memory as a learned skill. That convergence was significant.
As we look back on 2025, one thing is clear: artificial intelligence and data are no longer experimental tools sitting at the edges of organizations. They have moved decisively into the core of how businesses operate, compete, and create value. The pace of adoption tells the story. By the end of 2025, roughly one in six people worldwide had used generative AI tools, according to Microsoft’s AI Diffusion Report. In enterprises, momentum was even stronger, with nearly 70% of global organizations deploying generative AI in at least one business function by mid-year. What began as isolated pilots has rapidly evolved into embedded capabilities affecting decision-making, customer engagement, and operational efficiency.
In the high-stakes aviation landscape, On-Time Performance (OTP) is one of the primary levers for operational profitability. For a Tier-1 carrier, the financial impact of operational slippage has reached a critical threshold. As of 2024/2025, a single minute of delay costs an average of $100.76 in direct operating expenses.
The pharmaceutical industry stands at a decisive moment. The EU AI Act's August 2026 compliance deadline for high-risk AI systems is not merely a regulatory hurdle - it is a strategic inflection point that will redefine the competitive landscape for BioPharma. Most organizations frame this as a compliance burden. The market leaders are already recognizing it as a strategic opportunity: the chance to build a scalable trust stack (governance, assurance, adoption) that accelerates the molecule-to-market journey and builds a defensive moat around their data assets.
The recent share price slide of CRE firms on the fears of existential AI disruptions to their business model is a manifestation of a new reality starting to take shape. Reflecting on the future of the built environment often feels like standing at a precipice. In my recent discussions with industry leaders, I’ve found that the conversation usually gravitates toward two extremes: a techno-utopia of total, automated efficiency or a stubborn, cautious return to the "human touch."
This article shows how marketers can move beyond standard platform AI by combining first-party data, predictive signals, and smart infrastructure - turning generic automation into “signature dishes” that deliver higher ROI.
While AI has unlocked vast possibilities for the industry, large-scale implementation remains challenging. Overall, only a minority of retailers have successfully operationalized personalization at scale, and many organizations are still constrained by gaps in talent readiness and change management, slowing their transformation journeys.
In sport, data and AI are primarily associated with on-field performance: player analytics, tactical modelling and injury prevention. Technology has expanded the boundaries of athletic achievement, enabling athletes to push beyond previous limits. So why aren’t more sports organisations applying the same thinking to the business of sport? Sport is an intensely competitive entertainment industry where marginal gains in areas such as fan engagement, content, operations and commercial decision-making can matter as much as results.
